Representing the next generation Glaukos trabecular micro-bypass, the new precision-engineered iStent inject W features a wide flange at its base. This design evolution aims to optimise stent visualisation and placement, enhance procedural predictability, and increase confidence.
The iStent inject W is designed to reduce intraocular pressure by bypassing the primary source of resistance to improve aqueous outflow through the conventional pathway. It is indicated for the treatment of mild-tomoderate open angle glaucoma in patients undergoing cataract surgery or as a standalone procedure.
iStent inject W is built on a solid, dependable foundation of proven efficacy and safety. Trabecular micro-bypass, developed by Glaukos, has been studied extensively around the world and its efficacy has been demonstrated in over 140 peer-reviewed articles and over 650,000 eyes.
Contact: Glaukos Account Manager